Multiple Myeloma in the Era of Novel Agents: A Single-Center Study

被引：0
|
作者：
Lopes, Danielle Ovigli [1 ]
Arcuri, Leonardo [1 ]
Marques, Carolina [1 ]
Kerbauy, Mariana [1 ]
Moura, Fernando [1 ]
Helman, Ricardo [1 ]
Silva, Cinthya [1 ]
RIbeiro, Andreza [1 ]
Hamerschlak, Nelson [1 ]
机构：
[1] Hosp Israelita Albert Einstein, Sao Paulo, Brazil
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-261
引用
收藏
页码：S187 / S188
页数：2
相关论文
共 50 条
  • [31] Outcomes of Plasma Cell Leukemia Patients in the Era of Next-Generation Novel Agents: A Single-Center Retrospective Cohort Study
    Ge, Alex
    Huang, Chiung-Yu
    Martin, Thomas, III
    Wolf, Jeffrey L.
    Shah, Nina
    Wong, Sandy W.
    BLOOD, 2020, 136
  • [32] Improved survival of older patients with multiple myeloma in the era of novel agents
    Mey, Ulrich J. M.
    Leitner, Christoph
    Driessen, Christoph
    Cathomas, Richard
    Klingbiel, Dirk
    Hitz, Felicitas
    HEMATOLOGICAL ONCOLOGY, 2016, 34 (04) : 217 - 223
  • [33] The initial management of multiple myeloma in the era of novel agents: 2021 and beyond
    Nadeem, Omar
    Richardson, Paul G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (02) : 213 - 215
  • [34] Front line treatment of elderly multiple myeloma in the era of novel agents
    Venon, Marie-Dominique
    Roccaro, Aldo M.
    Gay, Julie
    Moreau, Anne-Sophie
    Dulery, Remy
    Facon, Thierry
    Ghobrial, Irene M.
    Leleu, Xavier
    BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 99 - 109
  • [35] Treatment of Multiple Myeloma in Akita: Features and Outcomes in the Era of Novel Agents
    Shida, Seiji
    Takahashi, Naoto
    Niioka, Takenori
    Kitabayashi, Atsushi
    Kawabata, Yoshinari
    Kume, Masaaki
    Saitoh, Hirobumi
    Hatano, Yoshiaki
    Ichikawa, Yoshikazu
    Kuroki, Jun
    Motegi, Mutsuhito
    Kobayashi, Takahiro
    Kameoka, Yoshihiro
    Tagawa, Hiroyuki
    Fujishima, Naohito
    Yoshioka, Tomoko
    Hirokawa, Makoto
    Miura, Masatomo
    Sawada, Kenichi
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2014, 54 (01) : 89 - 93
  • [36] A New Prognostic Model for Multiple Myeloma Patients in the Era of Novel Agents
    Cho, Hyungwoo
    Yoon, Dok Hyun
    Kim, Kihyun
    Yoon, Sung-Soo
    Min, Chang-Ki
    Eom, HyeonSeok
    Kim, Jin Seok
    Lee, Je-Jung
    Lee, Jae Hoon
    Suh, Cheolwon
    BLOOD, 2015, 126 (23)
  • [37] Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Novel Agents
    Shimazaki, Chihiro
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (01): : 14 - 15
  • [38] Evaluation of prognostic staging systems of multiple myeloma in the era of novel agents
    Shang, Yufeng
    Jin, Yanxia
    Liu, Hailing
    Ding, Lu
    Tong, Xiqin
    Tu, Honglei
    Zang, Longkai
    Lin, Chenyao
    Hu, Jinsong
    Zhou, Fuling
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (02) : 212 - 222
  • [39] A New Prognostic Index for Multiple Myeloma Patients in the Era of Novel Agents
    Cho, Hyungwoo
    Suh, Cheolwon
    Yoon, Dok Hyun
    Park, Ji Hyun
    Kim, Shin
    Lee, Sang-wook
    Park, Chan-Sik
    Huh, Jooryung
    Lee, Kyoungmin
    Kang, Eun Hee
    Park, Jung Sun
    Park, Chan-Jeoung
    Kim, Jin Seok
    Kim, Kihyun
    BLOOD, 2014, 124 (21)
  • [40] MELANOMA BRAIN METASTASES IN THE ERA OF NOVEL THERAPIES: A SINGLE-CENTER, DUTCH COHORT STUDY
    Derks, S. H. A. E.
    Jongen, J. L. M.
    Slagter, C.
    Joosse, A.
    Schouten, J. W.
    van den Bent, M. J.
    van der Veldt, A. A. M.
    NEURO-ONCOLOGY, 2021, 23 : 43 - 43
12345